Copyright: ©Author(s) 2026.
World J Gastroenterol. Jan 14, 2027; 33(2): 124419
Published online Jan 14, 2027. doi: 10.3748/wjg.124419
Published online Jan 14, 2027. doi: 10.3748/wjg.124419
Figure 2 CONSORT flow diagram.
Patients without an evaluable 8-week endoscopic assessment were imputed as treatment failures in the modified intention-to-treat and full intention-to-treat analyses; these patients were among those excluded from the per-protocol population and do not constitute an additional group. ESD: Endoscopic submucosal dissection.
- Citation: Hyun HK, Hwang JH, Son NH, Gwon SH, Jung DH, Huh CW. Fexuprazan vs esomeprazole for endoscopic submucosal dissection-induced gastric ulcer healing: A double-blind randomized controlled trial. World J Gastroenterol 2027; 33(2): 124419
- URL: https://www.wjgnet.com/1007-9327/full/v33/i2/124419.htm
- DOI: https://dx.doi.org/10.3748/wjg.124419